A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis—in some cases even redirecting the course of care.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗